According to graphical abstract, biochemical assays and genotyping analysis supported by an in silico/bioinformatics study, as well as enrichment and survival analysis, suggest that CD295 rs6700986 and ITLN1 rs952804 SNPs could be considered, together with DNA damage, as BC-related risk factors. This evidence concerns the gene LEPR and breast cancer.